Danielle Smith says U.K. decision to limit access to puberty blockers is example for Alberta

Alberta’s premier says a decision this week by British health officials is in line with her government’s plans on transgender healthcare. Under a new policy, U.K. patients under the age of 18 will no longer be able to access puberty blockers unless they enroll in a clinical trial. That decision follows a four year review of published research, but critics say politics are at play. Heather Yourex-West reports.

• Alberta’s premier points to ‘increasing international evidence’ against puberty blockers to support policy